Show Summary Details
Page of

Elimination Diets for Food Reactions: Separating Fact from Fiction 

Elimination Diets for Food Reactions: Separating Fact from Fiction
Chapter:
Elimination Diets for Food Reactions: Separating Fact from Fiction
Author(s):

Jane Varney

, Chu K Yao

, Jane G. Muir

, and Peter R. Gibson

DOI:
10.1093/med/9780190933043.003.0005
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 09 May 2021

An abundance of diet therapies are proposed to treat chronic intestinal disorders such as the irritable bowel syndrome (IBS) and eosinophilic esophagitis (EoE). These commonly either eliminate or restrict specific foods and/or food components, based on the principle that even trace amounts induce an immune reaction (e.g., elimination diets for EoE), or, in the case of restrictive diets, that individuals have a threshold level of tolerance below which symptom control will be induced. The low-FODMAP (fermentable oligosaccharides, disaccharides, monosaccharides, and polyols) diet for IBS is one example of a restrictive diet based on sound rationale, robust efficacy data, comprehensive food composition information that is publicly available in a user-friendly form, and, increasingly, longitudinal data to demonstrate the long-term benefits. To optimize patient outcomes, health care professionals must be aware of the risks, benefits, and clinical indications for the use of diet therapies proposed to treat chronic intestinal disorders.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.